; and (B) is licensed to operate and dispense insulin to individuals in Canada, or, subject to subsection (e), the permitted country in which the pharmacy is located. (5) Qualifying insulin The term qualifying insulin means insulin that— (A) is approved for use in patients, and marketed, in Canada, or subject to subsection (e), approved for use in patients, and marketed, in another permitted country; (B) is manufactured in a facility registered under subsection (b)(1) or (i) of section 510 that is in compliance with good manufacturing practices regulations of the Food and Drug Administration; (C) has the same active ingredient or ingredients, route of administration, and strength as an insulin approved under chapter V, or is biosimilar to an approved biological product and has the same route of administration and strength as the approved biological product; and (D) is labeled in accordance with— (i) the laws of Canada, or another country from which importation is permitted pursuant to subsection (e); and (ii) the requirements promulgated by the Secretary, which shall include labeling in English; (6) Valid prescription The term valid prescription means a prescription that is issued for a legitimate medical purpose in the usual course of professional practice by— (A) a practitioner who has conducted at least 1 in-person medical evaluation of the patient; or (B) a covering practitioner. (c) Publication of certified foreign sellers The Secretary shall publish on a dedicated internet website a list of certified foreign sellers, including the internet website address, physical address, and telephone number of each such certified foreign seller. (d) Additional criteria (1) Certified foreign sellers (A) In general To be a certified foreign seller, such seller shall— (i) be certified by the Secretary in accordance with subparagraph (B); (ii) pay the registration fee established under subparagraph (C)